tions reporting heritability estimates for different multifactorial diseases and claiming the existence of some socalled missing heritability [5] . In these computations of heritability ( table 1 ), the assumed model for multifactorial diseases is no longer a monogenic model but a polygenic additive one with a liability threshold [6] [7] [8] [9] . An infinite number of factors (both genetic and environmental) with weak, independent and additive effects are assumed to contribute to an underlying liability that is normally distributed, and a threshold is defined beyond which an individual is affected. Rather than the heritability of a multifactorial disease, it is thus the heritability of the liability of the disease that is estimated. It is also under this model that a novel method has been developed that allows the computation of heritability estimates from genome-wide association study data of unrelated individuals [10, 11] .
Is this model suitable for multifactorial diseases? Some argue that observations are consistent with this model [12] : the relative risks estimated at individual SNPs are weak, there is no evidence for statistical interaction between associated SNPs, and the variance explained by each chromosome is proportional to its length. However, consistency with a model does not mean that the model is true. It may simply result from In the search for the genetic factors underlying multifactorial diseases, the way is paved by epidemics of the GIGO (Garbage-In Garbage-Out) syndrome. Indeed, the use of simplistic models for these diseases leads to erroneous conclusions. The first epidemic of the GIGO syndrome occurred in the 1980s with the publication of the first comprehensive genetic maps of markers that enabled linkage analysis at the genome-wide level. During this decade, the lod score method, previously developed by Morton [1] to find genes involved in monogenic diseases, was used in the study of multifactorial diseases. The method requires the specification of a genetic model for the correspondence between the genotypes at the disease locus and the phenotype [2] . For most multifactorial diseases that involve multiple genetic and environmental risk factors, this correspondence is not known. The simple model used for monogenic diseases that assumes a rare, highly penetrant, dominant or recessive gene mutation is irrelevant for multifactorial diseases. This did not prevent researchers from using this model, and numerous tables of meaningless lod scores were published at that time, leading to invalid conclusions [3] .
Since the first report of the complete human genome sequence in 2008 [4] , we have witnessed a dramatic resurgence of the GIGO syndrome, with numerous publica-the poor information available and a lack of power to reject the model. In particular, information on individual SNPs is useful to detect susceptibility loci, as evidenced by multiple replicated genome-wide association study hits, but it is very inefficient for measuring gene effects. The contrast between patients and controls concerning biallelic markers does not allow a good estimation of the genotypic risks associated with functional variations that are likely to be more complex than a single nucleotide change. This is the case for several disease susceptibility genes for which the information obtained from SNPs leads to an underestimation of the true genotypic risks and an incorrect classification of individuals in risk categories. Examples include the insulin gene in type 1 diabetes [13, 14] , PTPN22 in rheumatoid arthritis [15, 16] , IL2RA in multiple sclerosis [17, 18] and HLA in celiac disease [19] [20] [21] [22] ( table 2 ). Assuming that a multifactorial disease is triggered by the small and independent effects of many factors is overly simplistic.
Nonetheless, many studies of multifactorial diseases keep evaluating the heritability under the additive polygenic model, whereas genetic variance and consequently heritability estimates strongly depend on the genetic model assumed for disease transmission. Heritability estimates for the liability to schizophrenia vary from about 10-15% under a monogenic model to >75% under an additive polygenic model [23] , and half of the latter value under a more complex model involving interactions between pathways [24] . Even though all these models fit the recurrence risks of schizophrenia in relatives, they lead to very different heritability estimates. Which of these estimates is correct? It is not possible to say, and they are probably all wrong, since for schizophrenia -as well as for the majority of multifactorial diseases -the underlying model is not known. Multifactorial diseases most likely have a very complex and heterogeneous etiology. This is well illustrated by the evolution of heritability estimates for the liability to diabetes before (heritability 0.75) [25] and after the differentiation between various forms of diabetes: monogenic (MODY), type 1 diabetes (heritability 0.88) [26] and type 2 diabetes (heritability 0.26) [27] . The genetic homogeneity of the liability to type 2 diabetes is itself questionable [28] . Most of the assumed models are too simplistic to allow any useful prediction.
Not only do heritability estimates depend on the underlying genetic model, but they also depend on the environmental variance. If there is no environmental variance, as for example in the case of tuberculosis in a population homogeneously exposed to Koch bacillus, the 
PTPN22 in rheumatoid arthritis
The OR for SNP rs2476601 reported as to be associated with rheumatoid arthritis [16] is estimated at 1.6, whereas taking into account the information on 3 interactive SNPs of PTPN22, the relative risks for rheumatoid arthritis vary from 1 to 4.7 [15] . In addition, the use of only the information on SNP rs2476601 leads to a strong misclassification of individuals in terms of relative risks.
IL2RA and multiple sclerosis
The OR for SNP rs2104286 associated with multiple sclerosis in a genome-wide study [17] is estimated at 1.19, whereas the differential risk between the least and most at-risk genotype is 4 for the joint information provided by the 2 SNPs rs2256774 and rs3118470 [18] .
HLA and celiac disease
A genome-wide association study reported an association between a SNP (rs2187668) of the HLA region and celiac disease with an OR of 7 [19] , whereas the OR estimate is 8.4 for the HLA B8 antigen -known for more than 30 years to be associated with celiac disease [20] -and it is 27 for the HLA DQ2 heterodimer directly involved in the disease process [21, 22] . This heterodimer is encoded by 2 HLA genes interacting together, and its effect could not be summarized by just a biallelic polymorphism. An important proportion of heterodimer carriers (those encoding the heterodimer in the trans position) will be classified as having low risk when considering only the information provided by SNP rs2187668. If heritability estimates of human traits are so unreliable, then one may wonder why their use in human genetics is so widespread. It may stem from the strange game proposed to geneticists to search for the 'missing heritability of complex diseases' [29] . A clear winner in this game is the impact factor of Nature , with the number of citations of that single article ( [29] ) being >3,000 (and an additional one in this Commentary). Unfortunately, genetics is a clear looser, with a lack of diversity in the strategies used for the study of multifactorial diseases. It is particularly disturbing to observe that information available on marker-disease transmission in families -albeit essential for genetic modelling -is nowadays so often ignored by geneticists [30] .
GIGO epidemics seem to occur after major revolutions in genetics. Thanks to molecular biology, the progress on monogenic diseases during the last two decades of the 20th century has been incredible. In this new century, with the sequencing of the genome, we may also expect a huge advance in the understanding of human diseases, in particular with the identification of many monogenic subentities. It seems, however, that in their enthusiasm, geneticists have forgotten that most human diseases are very heterogeneous and complex. It took a long time to escape from the monogenic paradigm; it is now urgent to escape from the polygenic one! We support Nelson et al. [31] in their call for a paradigm change in quantitative genetics. The issue is even more crucial for multifactorial diseases as the quantitative liability variable is an unobserved abstract construction [32] . Preventing the GIGO syndrome requires a move away from simplistic models and the development of novel strategies, combining different sources of information to progress in the understanding of disease etiology [33] .
